CAPPELLINI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 2.408
EU - Europa 2.040
AS - Asia 1.322
Continente sconosciuto - Info sul continente non disponibili 160
SA - Sud America 104
AF - Africa 19
OC - Oceania 6
Totale 6.059
Nazione #
US - Stati Uniti d'America 2.366
IE - Irlanda 531
SG - Singapore 464
CN - Cina 433
SE - Svezia 357
DE - Germania 261
UA - Ucraina 241
RU - Federazione Russa 223
IT - Italia 205
TR - Turchia 159
HK - Hong Kong 101
BR - Brasile 80
FI - Finlandia 69
GB - Regno Unito 63
VN - Vietnam 56
IN - India 31
BD - Bangladesh 25
BE - Belgio 20
CA - Canada 16
FR - Francia 14
EU - Europa 13
PL - Polonia 13
AT - Austria 10
MX - Messico 9
NL - Olanda 9
IQ - Iraq 7
EC - Ecuador 6
JP - Giappone 6
ZA - Sudafrica 6
AU - Australia 5
CR - Costa Rica 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
CO - Colombia 4
DK - Danimarca 4
NI - Nicaragua 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AR - Argentina 3
CZ - Repubblica Ceca 3
ES - Italia 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PA - Panama 3
PK - Pakistan 3
RO - Romania 3
CL - Cile 2
IL - Israele 2
JO - Giordania 2
LU - Lussemburgo 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 5.915
Città #
Dublin 530
Chandler 367
Singapore 256
San Jose 190
Jacksonville 181
Ashburn 169
Izmir 150
The Dalles 123
Rome 107
Hong Kong 100
Boardman 89
Council Bluffs 88
Dallas 81
Ann Arbor 79
Wilmington 79
Nanjing 73
Beijing 63
Woodbridge 62
Moscow 57
Brooklyn 47
Hefei 47
Lawrence 46
Princeton 46
New York 33
Los Angeles 29
Ogden 29
Nanchang 28
Brandenburg 25
Bologna 23
Helsinki 23
Santa Clara 22
Milan 21
Brussels 20
Dearborn 19
Ho Chi Minh City 17
Munich 17
Changsha 16
Dong Ket 16
Orem 16
San Francisco 16
Columbus 15
Des Moines 14
Inglewood 14
Jiaxing 13
Orange 13
Tianjin 13
Hebei 12
Kunming 12
Falls Church 11
Hanoi 11
Seattle 11
Warsaw 11
Chicago 9
Shenyang 9
São Paulo 9
Cassino 8
Verona 8
Chennai 7
Hangzhou 7
Lanzhou 7
Phoenix 7
Salerno 7
Vienna 7
Boston 6
Buffalo 6
Fairfield 6
Pune 6
Amsterdam 5
Baghdad 5
Haikou 5
Manchester 5
Montreal 5
Nuremberg 5
San José 5
Tashkent 5
Ankara 4
Atlanta 4
Caracas 4
Denver 4
Frankfurt am Main 4
London 4
Ningbo 4
Tokyo 4
Toronto 4
Turku 4
Asunción 3
Changchun 3
Copenhagen 3
Figino 3
Hanover 3
Houston 3
Johannesburg 3
Kuala Lumpur 3
Managua 3
Minneapolis 3
Newark 3
Norwalk 3
Tappahannock 3
Zhengzhou 3
Abu Dhabi 2
Totale 3.783
Nome #
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 202
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 191
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. 187
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 185
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers. 165
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 157
Metabolism and signaling activities of nuclear lipids. 156
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. 152
Two hits are better than one: targeting both phosphatidylinositol3-kinase and mammalian target of rapamycin as a therapeuticstrategy for acute leukemia treatment 146
Flow cytometric detection of total and serine 473 phosphorylated Akt. 146
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 144
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 137
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB 137
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 136
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. 132
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 132
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 132
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 131
PI3K paninhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors 129
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia 128
Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells 127
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 127
The controversial nuclear matrix: a balanced point of view. 126
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 125
Supravital exposure to propidium iodide identifies apoptosis on adherent cells. 124
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. 124
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 123
Molecular characterization of protein kinase C-alpha binding to lamin A. 123
Targeting the liver kinaseB1/AMP-activated protein kinasepathway as a therapeutic strategyfor hematological malignancies 122
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 122
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 122
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 122
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. 121
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 120
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway 119
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation. 118
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 116
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 116
Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts. 115
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device. 114
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. 112
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 111
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia. 106
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) 103
Therapeutic targeting of CK2 in acute and chronic leukemias 91
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 85
Totale 6.059
Categoria #
all - tutte 29.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022333 0 0 0 26 35 9 7 34 10 17 69 126
2022/20231.568 103 145 57 154 87 261 0 93 622 5 17 24
2023/2024207 24 16 19 3 6 13 26 16 58 4 2 20
2024/2025662 24 12 44 9 54 10 72 59 235 6 68 69
2025/20261.341 77 222 58 49 130 133 284 44 55 158 76 55
2026/2027359 87 54 197 21 0 0 0 0 0 0 0 0
Totale 6.059